• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NasdaqGS
    93.52 Up 0.97(1.05%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:92.55
    Open:93.88
    Bid:74.12 x 100
    Ask:N/A
    1y Target Est:120.00
    Beta:2.17
    Earnings Date:Feb 11 - Feb 16 (Est.)
    Day's Range:93.32 - 95.73
    52wk Range:47.03 - 112.57
    Volume:162,297
    Avg Vol (3m):733,328
    Market Cap:7.19B
    P/E (ttm):N/A
    EPS (ttm):-5.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALNY

    Comparison

    Symbol% ChgMkt Cap
    ALNYUp 1.05%7.19B
    MRKUp 0.44%163.81B
    PFEDown 0.10%197.97B
    VRXDown 0.16%47.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):190.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-5.31
    Quarterly EPS Est (Dec-14) :-0.60
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-0.38

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback